Complaint received reporting (filter) leakage issue with use of one b6008 0.2 micron filter.The b6008 device was pre-tested/primed prior to placement with no issues noted at that time.The device was initially placed on (b)(6) 2014, one infusion of etoposide (131 mg/700 ml) running at 29ml/hr for 24 hour duration was administered without incident.The b6008 device was removed, replaced and discarded.There were no injuries or adverse consequences to the clinicians, patient or family members that were present.
|